apomorphine has been researched along with prochlorperazine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Da Prada, M; Haefely, W; Pieri, L; Pieri, M; Schaffner, R | 1 |
| Balster, RL; Harris, LS; Landauer, MR | 1 |
| Weissman, A | 1 |
| Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Schellekens, KH | 1 |
| Boissier, JR; Lwoff, JM; Simon, P | 1 |
| BHARGAVA, KP; CHANDRA, O | 1 |
| JUSTIN-BESANCON, L; LAVILLE, C | 1 |
| Obata, Y; Otake, Y; Takayama, K | 1 |
| Baig, AM; Khan, NA; Kulsoom, H; Siddiqui, R | 1 |
1 review(s) available for apomorphine and prochlorperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for apomorphine and prochlorperazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
Topics: 5,7-Dihydroxytryptamine; Animals; Apomorphine; Behavior, Animal; Brain Injuries; Catalepsy; Ergolines; Female; Haloperidol; Humans; Hydroxydopamines; Lysergic Acid Diethylamide; Male; Medial Forebrain Bundle; Neural Pathways; Prochlorperazine; Rats; Rotation; Urea | 1978 |
Attenuation of cyclophosphamide-induced taste aversions in mice by prochlorperazine, delta 9-tetrahydrocannabinol, nabilone and levonantradol.
Topics: Animals; Apomorphine; Avoidance Learning; Cyclophosphamide; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Phenanthridines; Prochlorperazine; Taste | 1985 |
Psychopharmacological effects of thiothixene and related compounds.
Topics: Animals; Apomorphine; Avoidance Learning; Body Temperature; Catalepsy; Chlorpromazine; Dextroamphetamine; Discrimination, Psychological; Dogs; Drug Synergism; Ethanol; Hexobarbital; Humans; Male; Mice; Mortality; Phenothiazines; Prochlorperazine; Psychopharmacology; Rats; Reflex; Tranquilizing Agents; Tremor | 1968 |
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and
Topics: Acepromazine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benperidol; Chlorpromazine; Chlorprothixene; Fluphenazine; Haloperidol; Male; Mastication; Methods; Motor Activity; Norepinephrine; Perphenazine; Phenothiazines; Prochlorperazine; Promazine; Rats; Thiazines; Thioridazine; Tranquilizing Agents; Trifluoperazine; Triflupromazine; Trimeprazine | 1967 |
[Pharmacologic studies of a prolonged action neuroleptic: fluphenazine enanthate].
Topics: Animals; Apomorphine; Behavior, Animal; Chloral Hydrate; Dextroamphetamine; Drug Synergism; Fluphenazine; Male; Mice; Pentobarbital; Prochlorperazine; Rats | 1966 |
ANTI-EMETIC ACTIVITY OF PHENOTHIAZINES IN RELATION TO THEIR CHEMICAL STRUCTURE.
Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Chemistry, Pharmaceutical; Chlorpromazine; Dogs; Perphenazine; Pharmacology; Phenothiazines; Prochlorperazine; Research; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1963 |
[ANTIEMETIC ACTION OF METOCLOPRAMIDE WITH RESPECT TO APOMORPHINE AND HYDERGINE].
Topics: Antiemetics; Apomorphine; Benzamides; Cardiovascular Agents; Chlorpromazine; Dihydroergotoxine; Diphenhydramine; Dogs; Ergoloid Mesylates; Ergot Alkaloids; Metoclopramide; Oxytocics; Pharmacology; Prochlorperazine; Research; Toxicology | 1964 |
Feasibility of transdermal delivery of prochlorperazine.
Topics: Administration, Cutaneous; Animals; Antiemetics; Apomorphine; Chromatography, High Pressure Liquid; Drug Delivery Systems; Feasibility Studies; Hydrogels; In Vitro Techniques; Male; Mice; Mice, Hairless; Permeability; Prochlorperazine; Skin; Skin Absorption; Stereotyped Behavior | 2010 |
Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amiodarone; Amlodipine; Apomorphine; Balamuthia mandrillaris; Brain; Cells, Cultured; Digoxin; Drug Synergism; Drug Therapy, Combination; Encephalitis; Endothelial Cells; Haloperidol; Humans; Loperamide; Microvessels; Prochlorperazine; Procyclidine | 2014 |